Strategic Wealth Partners, Ltd. Bristol Myers Squibb CO Transaction History
Strategic Wealth Partners, Ltd.
- $1.14 Billion
- Q2 2025
A detailed history of Strategic Wealth Partners, Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Strategic Wealth Partners, Ltd. holds 3,824 shares of BMY stock, worth $176,171. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,824
Previous 4,994
23.43%
Holding current value
$176,171
Previous $282,000
37.23%
% of portfolio
0.02%
Previous 0.03%
Shares
26 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.64BCall Options Held
22.5MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA195MShares$8.98 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.31 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.98 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.36 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.26 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $98B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...